Do the downloads!! Share!! The diffusion of very important information and knowledge is essential for the world progress always!! Thanks!!
- – > Mestrado – Dissertation – Tabelas, Figuras e Gráficos – Tables, Figures and Graphics – ´´My´´ Dissertation @ #Innovation #energy #life #health #Countries #Time #Researches #Reference #Graphics #Ages #Age #Mice #People #Person #Mouse #Genetics #PersonalizedMedicine #Diagnosis #Prognosis #Treatment #Disease #UnknownDiseases #Future #VeryEfficientDrugs #VeryEfficientVaccines #VeryEfficientTherapeuticalSubstances #Tests #Laboratories #Investments #Details #HumanLongevity #DNA #Cell #Memory #Physiology #Nanomedicine #Nanotechnology #Biochemistry #NewMedicalDevices #GeneticEngineering #Internet #History #Science #World
The influence of physical activity in the progression of experimental lung cancer in mice
- PMID: 22683274
- DOI: 10.1016/j.prp.2012.04.006
GRUPO_AF1 – GROUP AFA1 – Aerobic Physical Activity – Atividade Física Aeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto
GRUPO AFAN 1 – GROUP AFAN1 – Anaerobic Physical Activity – Atividade Física Anaeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto
GRUPO_AF2 – GROUP AFA2 – Aerobic Physical Activity – Atividade Física Aeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto
GRUPO AFAN 2 – GROUP AFAN 2 – Anaerobic Physical Activity – Atividade Física Anaeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto
Slides – mestrado – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto
DMBA CARCINOGEN IN EXPERIMENTAL MODELS
Avaliação da influência da atividade física aeróbia e anaeróbia na progressão do câncer de pulmão experimental – Summary – Resumo – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto
Lung cancer is one of the most incident neoplasms in the world, representing the main cause of mortality for cancer. Many epidemiologic studies have suggested that physical activity may reduce the risk of lung cancer, other works evaluate the effectiveness of the use of the physical activity in the suppression, remission and reduction of the recurrence of tumors. The aim of this study was to evaluate the effects of aerobic and anaerobic physical activity in the development and the progression of lung cancer. Lung tumors were induced with a dose of 3mg of urethane/kg, in 67 male Balb – C type mice, divided in three groups: group 1_24 mice treated with urethane and without physical activity; group 2_25 mice with urethane and subjected to aerobic swimming free exercise; group 3_18 mice with urethane, subjected to anaerobic swimming exercise with gradual loading 5-20% of body weight. All the animals were sacrificed after 20 weeks, and lung lesions were analyzed. The median number of lesions (nodules and hyperplasia) was 3.0 for group 1, 2.0 for group 2 and 1.5-3 (p=0.052). When comparing only the presence or absence of lesion, there was a decrease in the number of lesions in group 3 as compared with group 1 (p=0.03) but not in relation to group 2. There were no metastases or other changes in other organs. The anaerobic physical activity, but not aerobic, diminishes the incidence of experimental lung tumors.
Copyright © 2012 Elsevier GmbH. All rights reserved.
Data – Time – Database – Websites – Information – Respect – E-mails – Archives – Research – Reading – Probability – Innovations – Messages – Message @ Energy – Improvement – Probabilities – Intelligence – Technologies – Countries – Mind – Goals – Longevity – Science – Analysis – Work – Country – City – Money – Price – Cities – Life Experiences – Thinking – Communications – Cities – People – Friendship – Knowledgment – Friendships – Acts – Person – Health – Diseases – Lives – Time – Life – Write – Communication – Links – Humans – DNA – Link – Genetics – Thinking – RNA – Mice – Mouse – Speak – Type – Thoughts – Paper – Articles – Researches – Journal – Nature – Detail – Visibility – Journals – Magazines – References – Utility – Age – Efficiency – Reflections – Articles – Laboratory – Papers – Content – Issue – Subject – Phrases – Click – Affirmation – Imagination – Name – Issues – Thoughts – Details – Investigations – Intentions – Graphics – Science Events – Subjects – Blogs – Internet Society – Statistics – Interpretation – Reality – Society – Laboratories – Phrase – Affirmations – Questions – Virtuality – Investments – Graphics – Personal Opinions – Scientific Discoveries – Videos – Photos – Scientific Discovery – Opinion – Projects – Graphic -Economy – Money – Price – Impact – Context – Images – Ideas – History – Words – World @
Coronavirus clue? Most cases aboard U.S. aircraft carrier are symptom-free @ Trumpists Believe Bill Gates Is Using Coronavirus to Implant Brain Chips @ April 16 COVID-19 Update from Kent Scientific – Additional Questions? Our product specialists are here to help with additional information on our products, grant proposals, orders and more. Call 888-572-8887 – Link About Kent Scientific @ Animal Researches & Time & Countries @ History & Where Do New Genes Come From? @ Working in isolation to find a cure for COVID-19 – Li Hua is seeking drugs that can treat people infected with the coronavirus. @ Coronavirus: Scientists in China find 33 mutations of virus in warning to vaccine developers – Researchers say vaccine developers need to consider the impact of these “accumulating mutations… to avoid potential pitfalls” @ Como a imunologia pode contribuir pra o controle da COVID-19 – YouTube Video & A look back at medical advances in 2019 and the role played by animal research @ ´´What animals are used in coronavirus research? In the search for vaccines and treatments for Covid-19 animals can play an essential role in both basic research and testing. Various animal species are currently being bred and used as suitable models for predicting what effects a vaccine or treatment for Covid-19 may have on the human body.´´ @ COVID-19 vaccine protects monkeys from new coronavirus, Chinese biotech reports – By Jon Cohen – Apr. 23, 2020, 1:05 PM @ Scientists find genes can determine if you are at higher risk for fatal COVID-19 – John Anderer April 20, 2020
Coronavirus: Scientists in China find 33 mutations of virus in warning to vaccine developers – Researchers say vaccine developers need to consider the impact of these “accumulating mutations… to avoid potential pitfalls” @ Como a imunologia pode contribuir pra o controle da COVID-19 – YouTube Video
* Link about my monograph: Induction of benzonidazole resistance in human isolates of Trypanosoma cruzi: https://science1984.wordpress.com/2018/07/15/my-monography-chagas-disease-research-in-laboratory-2/
-Link about animal model diseases like cardiovascular diseases: https://science1984.wordpress.com/2020/04/29/33426/
– Links related with my dissertation: https://science1984.wordpress.com/2019/11/28/links-of-my-dissertation-the-influence-of-physical-activity-in-the-progression-of-experimental-lung-cancer-in-mice-and-monograph-induction-of-benzonidazole-resistance-in-human-isolates-of-trypanoso/
One of the largest COVID-19 vaccine trials currently underway will have over 500 volunteers actively testing its solution by the middle of next month. Researchers at the University of Oxford have already secured that number of participants, including a representative sample of people between the ages of 18 to 55, for a large-scale randomized clinical early and mid-stage trial of its potential vaccine, which uses a harmless, modified virus to trigger an immune response that is also effective against the novel coronavirus.
The trial will divide a total of 510 participant sent five groups, with one group receiving a follow-up, booster shot of the vaccine after the original does. The technology behind the vaccine has already been used in developing about 10 different other treatments, but will require an approach that includes setting up different test groups in different countries to ensure representative results, since infection rates are varying greatly place to place with prevention measures in place, study lead Sarah Gilbert told Bloomberg.
The team behind the vaccine is also still seeking additional funding to help scale manufacturing, since it aims to begin producing it in volume following the six month period this human trial phase will span. The goal is to have mass production up and running by this fall, under the assumption that the trial proves the potential vaccine effective, with a final stage trial of 5,000 people and the potential to begin providing some doses for use by frontline healthcare workers by as early as September.
The Oxford trial is one of just a handful that have progressed to the human testing phase, but more are coming online all the time. Existing clinical human trials from Moderna and Inovio are underway in the U.S., and those have also expressed the potential for earlier access for emergency use prior to broad rollout following the initial clinical results.
Even if there is some availability by fall of some of these vaccine candidates (and that assumes they even prove effective), that doesn’t mean they’ll be broadly available: That will still require further testing, and scaling manufacturing, as well as working out distribution and administration – all processes that will add months of work. Already, however, the unprecedented nature of the COVID-19 pandemic has resulted in new efficiencies in the development process, and more could follow in these extraordinary times.
Preliminary Study Claims To Have Discovered The First Significant Mutation In The SARS-CoV-2 Pathogen
A preliminary study reports that a significant mutation in the SARS-CoV-2 pathogen may have been detected for the first time. Authors of the study, published on the website bioRxiv and not yet peer-reviewed, posit that if the mutations continue to occur, it could impact efforts to find a vaccine, but they told Newsweek they think this is unlikely due to the genome’s relatively stable nature compared to the SARS coronavirus.
The study looked at the genetic makeup of 106 samples of the Covid-19 pathogen from a database compiling information taken from infections across the globe. They then compared the information on the Covid-19 coronavirus with 39 genome sequences of the SARS coronavirus. SARS causes severe acute respiratory syndrome, which saw an outbreak in 2002.
Their investigations revealed that, despite having had a smaller impact on humanity, SARS actually contained higher genetic diversity with a greater rate of mutation compared to the Covid-19 pathogen, which was found to have a comparatively stable genome. The “first significant” mutation they did encounter was from a sample collected in India on January 27, 2020, which showed an alteration to the genome that appeared to make the pathogen less able to bind to a receptor on human cells called ACE2.
“A relatively stable genome of SARS-CoV-2 is a good indication for the epidemic control, as less mutation raises the hope of the rapid development of [a valid] vaccine and antiviral drugs,” wrote the authors.
The seasonal influenza (flu) has long been a headache for epidemiologists as a high mutation rate means that vaccinations become invalid from one flu season to the next (though there is promise that a universal vaccine may now be on the cards). Vaccines help the body to fight off serious illness by training our immune systems to recognize the pathogen once it enters our bodies. If the pathogen has mutated too significantly since the vaccine was developed, our immune cells won’t be able to recognize it and we’ll experience a more significant bout of illness.
If the SARS-CoV-2 genome is indeed stable, as the researchers believe their investigations indicate, then the mutation doesn’t necessarily spell bad news for vaccination efforts. A promising finding from the study was that the spike protein, which is a key feature that enables it to attack human cells, had stayed the same after the mutation.
The study has not yet undergone peer review, a vigorous process that establishes the methodology and results of the study are accurate. While this kind of publishing can help spur discussions, it also means concrete conclusions must be suspended until the research is validated.
- O segredo para comprar na Adidas que as pessoas não sabem www.cuponomia.com.br
- Zumbido: Fácil demais para funcionar? Esse truque científico silencia o ruído em segundos, mas é tão simples que até um bebê pode fazê-lo Acabar com Zumbido
- Disfunção erétil: Veja como resolver o problema e ser novamente um homem de verdade até o final do Segunda-feira Homem de Aço
- Brasileiros Não Pagam Mais TV a Cabo Graças a Esta Antena! MaxTV com 50% de desconto!
- Diabetes: Mulher de Rio Preto descobriu segredo que reduz seu açúcar no sangue paraníveis saudáveis – enquanto come seus alimentos favoritos Livre da Diabetes
- Vida independente para idosos pode ser maravilhosa Veja estas casas de repouso Senior Living | Sponsored Listings
- FBI Finds Horrific Frankenstein-Like Experiments At Body Donation Facility In Arizona
- 3 Mild Symptoms Could Predict Which Coronavirus Patients Develop Severe Lung Disease, Research Suggests
- 10 Coronavirus Symptoms You May Not Be Aware Of, From Malaise And Dizziness To Digestive Issues
- Why Are There So Few Coronavirus Cases In Russia And Africa?
- This Woman’s Mystery Weight Gain Turned Out To Be Something Much More Disturbing
- Cat Parasite Linked To Development Of Mental Illness In Owners
IF YOU LIKED THIS STORY, YOU’LL LOVE THESE
WASHINGTON (Reuters) – Sweeping testing of the entire crew of the coronavirus-stricken U.S. aircraft carrier Theodore Roosevelt may have revealed a clue about the pandemic: The majority of the positive cases so far are among sailors who are asymptomatic, officials say.
The possibility that the coronavirus spreads in a mostly stealthy mode among a population of largely young, healthy people showing no symptoms could have major implications for U.S. policy-makers, who are considering how and when to reopen the economy.
It also renews questions about the extent to which U.S. testing of just the people suspected of being infected is actually capturing the spread of the virus in the United States and around the world.
The Navy’s testing of the entire 4,800-member crew of the aircraft carrier – which is about 94% complete – was an extraordinary move in a headline-grabbing case that has already led to the firing of the carrier’s captain and the resignation of the Navy’s top civilian official.
Roughly 60 percent of the over 600 sailors who tested positive so far have not shown symptoms of COVID-19, the potentially lethal respiratory disease caused by the coronavirus, the Navy says. The service did not speculate about how many might later develop symptoms or remain asymptomatic.
“With regard to COVID-19, we’re learning that stealth in the form of asymptomatic transmission is this adversary’s secret power,” said Rear Admiral Bruce Gillingham, surgeon general of the Navy.
The figure is higher than the 25% to 50% range offered on April 5 by Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and a member of President Donald Trump’s coronavirus task force.
‘DISCONCERTING’ DATA FOR PENTAGON
Defense Secretary Mark Esper, speaking in a television interview on Thursday, said the number of asymptomatic cases from the carrier was “disconcerting.”
“It has revealed a new dynamic of this virus: that it can be carried by normal, healthy people who have no idea whatsoever that they are carrying it,” Esper told NBC’s “Today” morning show.
Such data present challenges to the Pentagon, which is deployed around the world, sometimes in confined environments like submarines, ships and aircraft.
Testing the entire military is not yet feasible, given still-limited testing capacity, officials say, and detecting enough cases without tests is impossible if most cases are asymptomatic.
The U.S. coronavirus death toll – the highest in the world – surged past 31,000 on Thursday after doubling in a week.
It also claimed the life of a sailor from the Theodore Roosevelt this week. Five other members of the crew are hospitalized.
Still, the case of the Theodore Roosevelt offers a case study for researchers about how the virus spreads asymptomatically in a confined environment among mostly younger adults.
That cohort has been somewhat underrepresented in the epidemiological data so far, said William Schaffner, an infectious disease specialist at Vanderbilt University Medical Center.
“The findings are of enormous interest because the proportion of people who are asymptomatic is just simply not known,” Schaffner said, when asked about the Navy’s data.
Vice Admiral Phillip Sawyer, a deputy chief of naval operations at the center of the Navy’s coronavirus response efforts, presented the 60% figure in a call with a small group of reporters on Wednesday.
But he declined to speculate about the implications.
“I don’t know if we’re proving something different,” Sawyer said.
“I do agree that we are providing some data that some other organizations might not have.”
Reporting by Phil Stewart and Idrees Ali; Editing by Mary Milliken and Jonathan Oatis
MORE FROM REUTERS
U.S. states extend coronavirus shutdown, Trump unveils plan for return
WHO regrets Trump funding halt as global coronavirus cases top 2 million
Trump unveils three-stage process for states to end coronavirus shutdown
New York governor attacks Trump for ‘passing buck’ on pandemic response
Exclusive: New York taps McKinsey to develop ‘Trump-proof’ economic reopening plan
REUTERS NEWS NOW
Subscribe to our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
“You’re not going to make black people the guinea pigs for this here right here,” Lynnette “Diamond” Hardaway said in a video.
“We’re not going to be your experiment or your project,” Rochelle “Silk” Richardson added.
Diamond and Silk, who have visited the White House on several occasions, been featured as campaign surrogates and been boosted by Trump, aren’t alone. Newsmax White House correspondent Emerald Robinson claimed last week that Gates wants to use “vaccines to track people,” while Fox News host Laura Ingraham—who has met with Trump to discuss the coronavirus—tweeted that Gates and other “globalists” want to use the crisis to track people. Gates’s name appeared on protest signs meant to criticize Ohio’s social distancing order, while former Trump adviser Roger Stone accused Gates of wanting to “microchip” people.
Amid the confusion caused by the coronavirus pandemic, Gates has emerged in fringe right circles as a villain behind the virus’s spread.
Gates has long been viewed suspiciously by vaccine skeptics, who take out-of-context remarks he made in 2011 about vaccines as proof that he wants to use inoculations to reduce the global population. In reality, Gates meant that reducing child mortality would help parents plan their families better.
In the coronavirus era, though, rumors and conspiracy theories about Gates have boomed. On social media, Gates has been wrongly accused of everything from plotting out the coronavirus pandemic ahead of time to distributing plush souvenir coronavirus toys to celebrate the virus’s death toll.
Gates has taken on the mastermind role in the right-wing conspiracy imagination typically reserved for billionaire Democratic donor George Soros, according to Brooke Binkowski, the managing editor of fact-checking site Truth or Fiction.
“These are all just recirculated, warmed-over stories—they’re just switching the names around,” Binkowski said. “George Soros was the bogeyman, now it’s Bill Gates.”
The disinformation campaign about Gates kicked off early in the spread of COVID-19, with QAnon conspiracy theorists claiming he had somehow patented the virus, with the implication that Gates was deliberately spreading the disease.
More recently, conspiracy theorists have claimed that Gates is somehow developing a tracking device to pair with any coronavirus vaccine. Some right-wing figures have even claimed Gates is developing the “mark of the Beast” predicted in the Book of Revelation. In fact, Gates’ foundation funded research in 2016 into using invisible ink to track child vaccination in developing countries, long before the coronavirus pandemic.
As for the coronavirus, Gates has pledged to fund the construction of seven different factories to help with production of seven potential vaccines. The investment will cost him billions because, in all likelihood, much of the money will go to waste. But he’s argued that it is worth it since it will dramatically reduce the time to scale up manufacturing as vaccine trial runs are conducted.
Nevertheless, the right-wing internet’s focus on Gates has proved to be fertile ground for internet tricksters. On April 10, for example, Microsoft released a commercial featuring its work with performance artist Marina Abramovic. Coincidentally, Abramovic is also a prominent player in the heated imaginations of Pizzagate conspiracy theorists, who believe she is somehow involved with child sacrifices at a Washington pizzeria.
An internet trickster quickly recut the ad, inserting a flashing “666” and images of Abramovic dancing in a satanic pentagram. The doctored ad circulated on Twitter as the genuine commercial, prompting people like one-time Pizzagate conspiracy theorist Mike Cernovich to claim in a tweet that Microsoft put a “666” message in the ad.
“Oh cool Microsoft did a video where ‘666’ flashes in the screen for a split second but if you point this out you’re a conspiracy theorist,” Cernovich wrote in a tweet, which he later deleted.
Microsoft eventually pulled the ad from YouTube. The Bill and Melinda Gates Foundation and Microsoft—whose board Gates left in March—didn’t respond to requests for comment.
The wild conspiracy theorizing around Gates isn’t just an internet phenomenon, Binkowski fears. Instead, it could end up having real world, highly damaging, impacts on the efforts to fight the coronavirus pandemic by convincing people to reject getting a vaccine for fear that it’s some sort of brain chip.
“It’s going to have the end effect of scaring more Americans away from vaccines,” Binkowski said.
April 16 COVID-19 Update from Kent Scientific
To keep our staff and community safe, most of our team continues working from home.
We are grateful to our core staff who maintain our operations and continue to provide the research community with a steady source for their equipment during this difficult period. We remain able to fulfill your orders, answer your questions and provide the superior product support and service you are accustomed to.
We thank you for your continued support and wish that you, your colleagues and loved ones remain safe.